Maintenance fees coming due
8 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Jan 16, 2027. Unpaid by Jul 16, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,351,621 | Anti-Histone Therapy in Acute Kidney Injury In force Fee due Jan 16, 2027 Lapses if unpaid Jul 16, 2027 · High confidence | Immunomedics, Inc. | In force | Jan 16, 2027 | Jul 16, 2027 | High confidence | |
| US 9,107,960 | ANTIBODY-SN-38 Immunoconjugates with a CL2A Linker In force Fee due Feb 18, 2027 Lapses if unpaid Aug 18, 2027 · High confidence | Immunomedics, Inc. | In force | Feb 18, 2027 | Aug 18, 2027 | High confidence | |
| US 9,115,172 | Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules In force Fee due Feb 25, 2027 Lapses if unpaid Aug 25, 2027 · High confidence | Immunomedics, Inc. | In force | Feb 25, 2027 | Aug 25, 2027 | High confidence | |
| US 10,413,539 | Therapy for Metastatic Urothelial Cancer with the Antibody-Drug Conjugate, Sacituzumab Govitecan (IMMU-132) In force Fee due Mar 17, 2027 Lapses if unpaid Sep 17, 2027 · High confidence | Immunomedics, Inc. | In force | Mar 17, 2027 | Sep 17, 2027 | High confidence | |
| US 10,436,788 | Isolation, Detection, Diagnosis And/Or Characterization of Circulating TROP-2-Positive Cancer Cells In force Fee due Apr 8, 2027 Lapses if unpaid Oct 8, 2027 · High confidence | Immunomedics, Inc. | In force | Apr 8, 2027 | Oct 8, 2027 | High confidence | |
| US 9,180,205 | Stable Compositions of High-Concentration Allotype-Selected Antibodies for Small-Volume Administration In force Fee due May 10, 2027 Lapses if unpaid Nov 10, 2027 · High confidence | Immunomedics, Inc. | In force | May 10, 2027 | Nov 10, 2027 | High confidence | |
| US 9,226,973 | Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity In force Fee due Jul 5, 2027 Lapses if unpaid Jan 5, 2028 · High confidence | Immunomedics, Inc. | In force | Jul 5, 2027 | Jan 5, 2028 | High confidence | |
| US 9,278,129 | Methods of Treating Rapidly Progressive Glomerulonephritis Using Chimeric and Humanized Anti-Histone H4 Antibodies In force Fee due Sep 8, 2027 Lapses if unpaid Mar 8, 2028 · High confidence | Immunomedics, Inc. | In force | Sep 8, 2027 | Mar 8, 2028 | High confidence |
8 of 8 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.